1. The Japanese Circulation Society (JCS) joint study group. “Guidelines for Diagnosis and Management of Patients with Long QT Syndrome and Brugada Syndrome (JCS 2012)”; 2012. Available: http://www.j-circ.or.jp/guideline/pdf/JCS2013_aonuma_h.pdf.
2. The International Council for Harmonization. Guidance for Industry E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; 2005. Available: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm073153.pdf.
3. Ministry of Health. Labour and Walfare. “jutoku hukusayo sikkanbetu taiou Manual −ventricular tachycardia−”; 2009. Available: http://www.mhlw.go.jp/topics/2006/11/dl/tp1122-1k01.pdf.
4. Incidence of proarrhythmic effects from quinidine in the outpatient treatment of benign or potentially lethal ventricular arrhythmias;J Morganroth;Am J Cardiol,1985
5. Clinical safety profile of sotalol in the treatment of arrhythmias;LF Soyka;Am J Cardiol,1990